Inicio › Cáncer (todos los tipos) › Oregón › Portland
Ensayos clínicos de Cáncer (todos los tipos) en Portland, OR
34 estudios para Cáncer (todos los tipos) buscan participantes en centros de Portland y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- Providence Portland Medical Center /ID# 277727, Portland
A Study of ASP3082 in Adults With Advanced Solid Tumors
ReclutandoFase 1
- Oregon Health and Science University, Portland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
ReclutandoFase 1
- Oregon Health & Science University, Portland
A Study of PHN-012 in Patients With Advanced Solid Tumors
ReclutandoFase 1
- PHN-012-001 Site, Portland
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
ReclutandoFase 3
- Investigative Site, Portland
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
ReclutandoFase 3
- Oregon Health and Science University /ID# 280071, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Providence Health & Services, Portland
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ReclutandoFase 2/3
- Providence Portland Medical Center, Portland
- Oregon Health and Science University OHSU, Portland
Connect for Cancer Prevention Study (Connect)
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Kaiser Permanente Northwest, Portland
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
ReclutandoFase 1/2
- Oregon Health and Science University ( Site 3004), Portland
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
ReclutandoFase 1/2
- Oregon Health and Science University /ID# 272282, Portland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- Providence Cancer Institute, Portland
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
ReclutandoFase 1
- Providence Portland Medical Center, Portland
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
ReclutandoEstudio observacional
- Oregon Health and Science University, Portland
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Oregon Health and Science University, Portland
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
ReclutandoFase 2
- Oregon Health and Science University, Portland
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- y 2 más
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
ReclutandoFase 2
- OHSU Knight Cancer Institute, Portland
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- Northwest Cancer Specialists /ID# 275151, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Providence Cancer Institute Franz Clinic, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ReclutandoFase 2
- Oregon Health and Science University, Portland
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
ReclutandoFase 1
- GSK Investigational Site, Portland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Reclutando
- VA Portland Health Care System, Portland, OR, Portland
Galleri® in the Medicare Population.
ReclutandoSe aceptan voluntarios sanos
- OHSU CEDAR Clinical Trials Portland, Portland
- OHSU CEDAR Clinical Trials Richmond, Portland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ReclutandoFase 2
- Oregon Health & Science Institute (OHSU), Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Providence Neurological Specialties West, Portland
Beat Childhood Cancer Specimen Banking and Data Registry
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Randall Children's Hospital, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Portland
Observational Study of Iris Tumors
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Oregon Health & Science University, Portland
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutandoFase 1/2
- Oregon Health & Science University, Portland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutando
- Kaiser Permanente Northwest - Oncology Clinic, Portland
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX121 estudios
- New York City, NY109 estudios
- Boston, MA85 estudios
- Los Angeles, CA74 estudios
- Nashville, TN65 estudios
- Philadelphia, PA59 estudios
- Washington, DC58 estudios
- Durham, NC58 estudios
- Chicago, IL51 estudios
- Atlanta, GA49 estudios
- Seattle, WA49 estudios
- Arlington, VA48 estudios
Otros estudios en Portland
- Cáncer de pulmón de células no pequeñas46 estudios
- Cáncer de seno33 estudios
- Cáncer de próstata33 estudios
- Cáncer metastásico29 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Cáncer de pulmón26 estudios
- Leucemia mielógena aguda25 estudios
- Cáncer de endometrio24 estudios
- Carcinoma de células escamosas de cabeza y cuello19 estudios
- Cáncer de páncreas19 estudios
- Fallo cardíaco17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.